The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
You can get your doctor to try to get you in, there's some companies that offer blood tests that look at circulating DNA, that'll measure it. We're getting there. It's still probably five to 10 years away from being really cheap.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
what felt like you know very much a research method is now emerging as a a real clinical option there's methods now that can find cancers at at at an earlier point and a broad array of cancers
we're really at 100x better I mean it's like this is It's and you know that it's at that point you're talking about a finger drop of blood if you're 100x better than 10 mL you mean yeah
right behind them are you know 10x 100x more sensitive methods that are are absolutely going to move the needle in terms of our ability to find cancers um at a microscopic Point
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.